Akbar Esmaeili | Design of Experiments (DOE) | Editorial Board Member

Prof. Akbar Esmaeili | Design of Experiments (DOE) | Editorial Board Member

 Islamic Azad University | Iran

Prof. Akbar Esmaeili, Ph.D., is a highly accomplished Professor in the Department of Chemical Engineering at the North Tehran Branch, Islamic Azad University, Tehran, Iran, and also serves as the Managing Director of the PINK WHITE ROSE Knowledge Enterprise Company. He earned his Ph.D. in Organic Chemistry from Islamic Azad University and has established himself as an influential researcher in tissue engineering, polymer science, and biomaterials. His pioneering investigations focus on the construction of biocompatible polymer-based heart valve scaffolds using advanced electrospinning and nanotechnological approaches. Dr. Esmaeili’s studies explore polyurethane, chitosan, polyvinyl alcohol, and polyaniline composite scaffolds, designed for superior biocompatibility, elasticity, and anticoagulant performance, contributing immensely to the progress of cardiovascular regenerative medicine. He is internationally recognized among the World’s Top 2% Scientists by Stanford University, with an h-index of 27, over 144 scientific publications, and more than 3,203 citations, reflecting his outstanding research productivity and global academic influence. Proficient in sophisticated analytical techniques such as NMR, HPLC, FTIR, SEM, XRD, and AFM, he exhibits comprehensive expertise in experimental and characterization methods. As an editor and reviewer for numerous prestigious international journals, including Acta Biochimica Polonica and Journal of Developmental Biology and Tissue Engineering, Dr. Esmaeili continues to inspire innovation and excellence in the interdisciplinary fields of chemistry, nanotechnology, and biomedical engineering.

Aasma Shaukat | Clinical Trials and Statistical Designs | Best Researcher Award

Dr. Aasma Shaukat | Clinical Trials and Statistical Designs | Best Researcher Award

New York University | United States

Dr. Aasma Shaukat, M.D., M.P.H., is an internationally acclaimed gastroenterologist, epidemiologist, and academic leader recognized for her transformative contributions to colorectal cancer prevention, gastrointestinal outcomes research, and population health. She serves as Director of Gastrointestinal Outcomes Research, Robert M. and Mary H. Glickman Endowed Professor of Medicine, Professor of Population Health, Co-Director of the Translational Research Education and Career (TREC) Program, and Program Director for the KL2 Scholars Program at the Clinical and Translational Science Institute at NYU Grossman School of Medicine, while also serving as a staff physician at the VA New York Harbor Healthcare System. Before joining NYU, she led the Gastroenterology Section at the Minneapolis VA Health Care System and was a core investigator at the Center for Chronic Disease Outcomes Research, establishing herself as a national authority in outcomes-based gastroenterology. Dr. Shaukat holds an M.B., B.S. from The Aga Khan University Medical College in Karachi and an M.P.H. in International Health and Epidemiology from Johns Hopkins Bloomberg School of Public Health, followed by residency training in Internal Medicine at the State University of New York and fellowship training in Gastroenterology at Emory University School of Medicine. Board-certified in Internal Medicine and Gastroenterology, she has combined clinical expertise with advanced epidemiologic research to drive evidence-based improvements in digestive health and preventive care. Her research has shaped international colorectal cancer screening practices through landmark studies demonstrating the long-term mortality benefit of fecal occult blood testing, influencing screening guidelines worldwide. With more than 273 peer-reviewed publications and numerous invited lectures, Dr. Shaukat has become one of the most cited researchers in gastroenterology, with an h-index of 50, i10-index of 155, and over 9,245 citations according to Scopus, underscoring her scientific impact. Her work encompasses endoscopic quality improvement, health disparities, cost-effectiveness of screening programs, and novel noninvasive diagnostics for gastrointestinal diseases. In addition to her research, Dr. Shaukat is a dedicated mentor and educator who has guided countless trainees and junior faculty, championing diversity and inclusion in academic medicine. She serves on the Board of Trustees for the American College of Gastroenterology, chairs the Clinical Practice Section of the American Gastroenterological Association Institute, and contributes to several national advisory and planning committees, including ASCO GI, GIQUIC, PCORI, and the VA GI Field Advisory Board. A recipient of numerous prestigious honors such as the ASGE Endoscopic Research Mentoring Award, ACG MVP SCOPY Award for Colon Cancer Prevention, and NYU Research Mentor of the Year Award, she continues to shape the future of gastroenterology through innovation, mentorship, and leadership. Dr. Shaukat’s enduring legacy lies in her ability to merge clinical excellence, epidemiologic insight, and translational impact to advance gastrointestinal health globally and inspire the next generation of physician-scientists committed to research-driven healthcare transformation.

Profiles: Scopus Google Scholar | Orcid

Featured Publications

Udaikumar, J., Nimmagadda, Shaukat, A.,R., Ingawale, S., Lella, V. V., Vijayakumar, K., et al. (2025). Current perspectives on colorectal cancer screening and surveillance in the geriatric population. Current Gastroenterology Reports, 27(1), 34.

Singal, A. G., Quirk, L., Boike, J., Chernyak, V., Feng, Z., Giamarqo, G., Kanwal, F., … (2025). Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel. Hepatology, 82(3), 794–809.

Shaukat, A., Hu, J., Zhao, Y., Faulx, G., Augustin, A., Murphy, S., Stevens, E., et al. (2025). A randomized clinical trial of multi-level intervention to improve colorectal cancer screening rates at multiple federally qualified health care centers in New York City. Contemporary Clinical Trials, 108115.

Farooque, U., Murtaza, M., Umer, M., Johar, A., Aparna, F., Khan, A. R., Kumar, A., et al. (2025). Advancing health equity through telehealth: A systematic review and meta-analysis of remote vs. in-person weight-loss interventions among Black women with obesity. Current Obesity Reports, 14(1), 72.

Tang, C. Z., Delau, O. R., Katz, S., Axelrad, J. E., Hudesman, D., Shaukat, A., et al. (2025). Mild endoscopic disease activity is associated with adverse outcomes among older adults with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics.